Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort

The clinical phenotype of Systemic Sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort

(2021) Maria-Grazia Lazzaroni et al.   RHEUMATOLOGY

Real-world experience of tocilizumab in systemic sclerosis: potential benefit on lung function for anti-topoisomerase-positive patients

(2021) Yasir Suleman et al.   RHEUMATOLOGY

Natural variability in the disease course of SSc-ILD: implications for treatment

(2021) Madelon C. Vonk et al.   European Respiratory Review

Nintedanib in patients with systemic sclerosis‐associated interstitial lung disease: subgroup analyses by autoantibody status and skin score

(2021) Masataka Kuwana et al.   Arthritis & Rheumatology

Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition

(2021) Cosimo Bruni et al.   Journal of Scleroderma and Related Disorders

Predictors of progression in systemic sclerosis patients with interstitial lung disease

(2020) Oliver Distler et al.   EUROPEAN RESPIRATORY JOURNAL

Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets

(2020) Michael Mahler et al.   AUTOIMMUNITY REVIEWS

Presence of IgM anti‐topoisomerase I antibodies is associated with disease progression in anti‐topoisomerase I IgG positive systemic sclerosis

(2020) Maaike Boonstra et al.   Arthritis & Rheumatology

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

(2020) Anna-Maria Hoffmann-Vold et al.   ANNALS OF THE RHEUMATIC DISEASES

The power of the EUSTAR cohort: key findings to date and implicationsfor management of systemic sclerosis patients

(2020) Francesco Benvenuti et al.   Expert Review of Clinical Immunology

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

(2020) Dinesh Khanna et al.   Lancet Respiratory Medicine

Prognostic properties of anti-topoisomerase antibodies in patients identified by the ACR/EULAR 2013 systemic sclerosis criteria

(2019) Maaike Boonstra et al.   RHEUMATOLOGY

Phenotypes determined by cluster analysis and their survival in the prospective EUSTAR cohort of patients with systemic sclerosis

(2019) Vincent Sobanski et al.   Arthritis & Rheumatology

Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort

(2019) Anna-Maria Hoffmann-Vold et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual

(2019) Serena Fasano et al.   ANNALS OF THE RHEUMATIC DISEASES

Systemic sclerosis: recent insight in clinical management

(2019) Elisabetta Zanatta et al.   JOINT BONE SPINE

Using autoantibodies and cutaneous subset to develop outcome‐based disease classification in systemic sclerosis

(2019) Svetlana I. Nihtyanova et al.   Arthritis & Rheumatology

Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database

(2019) Camelia Frantz et al.   AUTOIMMUNITY REVIEWS

Reliability and Minimal Clinically Important Differences of FVC. Results from the Scleroderma Lung Studies (SLS-I and SLS-II)

(2018) Suzanne Kafaja et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Ongoing clinical trials and treatment options for patients with systemic sclerosis–associated interstitial lung disease

(2018) Dinesh Khanna et al.   RHEUMATOLOGY

Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening

(2017) Maria-Grazia Lazzaroni et al.   JOURNAL OF RHEUMATOLOGY

Survival and organ involvement in patients with limited cutaneous systemic sclerosis and anti-topoisomerase-I antibodies: determined by skin subtype or auto-antibody subtype? A long-term follow-up study

(2016) Pim Kranenburg et al.   RHEUMATOLOGY

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

(2015) Roberto M. Lang et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Thinking outside the box—The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect

(2015) Neha Srivastava et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Systemic sclerosis

(2015) Yannick Allanore et al.   Nature Reviews Disease Primers

Statistical review: frequently given comments

(2014) Stian Lydersen   ANNALS OF THE RHEUMATIC DISEASES

Systemic Sclerosis Sine Scleroderma: A Multicenter Study of 1417 Subjects

(2014) S. Diab et al.   JOURNAL OF RHEUMATOLOGY

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

(2013) Frank van den Hoogen et al.   ANNALS OF THE RHEUMATIC DISEASES

Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database

(2012) Florian M P Meier et al.   ANNALS OF THE RHEUMATIC DISEASES

High prevalence of occult left heart disease in scleroderma-pulmonary hypertension

(2012) Benjamin D. Fox et al.   EUROPEAN RESPIRATORY JOURNAL

The Many Faces of Scleroderma

(2008) Virginia D. Steen   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA